Literature DB >> 18815462

[Three cases of multiple infarcted regenerative nodules in liver cirrhosis after gastrointestinal hemorrhage].

Byung Seok Kim1, Chang Hyeong Lee.   

Abstract

An infarction of regenerative nodules in liver cirrhosis is a rare abnormality characterized by their coagulative necrosis. We presume that ischemic necrosis is induced by a sudden reduction in the portal and arterial blood flows after blood loss or shock. Most patients with infarcted regenerative nodules have experienced previous episodes of gastrointestinal hemorrhage. Awareness of the entity of infarcted regenerative nodules and its inclusion in the differential diagnosis of multiple hepatic nodules in liver cirrhosis is important, particularly in patients with an episode of gastrointestinal bleeding. The possible difficulty of differentiating infarcted regenerative nodules in liver cirrhosis from hypovascular hepatocellular carcinoma by initial imaging findings alone means that a liver biopsy and serial imaging might be helpful in the differential diagnosis. We report three cases of multiple infarcted regenerative nodules in liver cirrhosis after gastrointestinal hemorrhage.

Entities:  

Mesh:

Year:  2008        PMID: 18815462     DOI: 10.3350/kjhep.2008.14.3.387

Source DB:  PubMed          Journal:  Korean J Hepatol        ISSN: 1738-222X


  3 in total

1.  Multiple infarcted regenerative nodules in liver cirrhosis after decompensation of cirrhosis: a case series.

Authors:  Dieter Scholtze; Tanja Reineke; Beat Müllhaupt; Christoph Gubler
Journal:  J Med Case Rep       Date:  2010-11-23

2.  Hepatocellular carcinoma hidden by multiple infarcted regenerative nodules.

Authors:  Jin Ah Kim; Hye Sung Ahn; Haneul Park; Yoo Rim Seo; Ju Hyun Seo; Chang Wook Kim; Hee Yeon Kim
Journal:  Korean J Intern Med       Date:  2016-02-18       Impact factor: 2.884

3.  Multiple infarcted regenerative nodules in liver, spleen and kidney after gastric and oesophageal bleeding: A case report.

Authors:  Anlong Wang; Yefei Shu
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.